The landscape of diabetes care is advancing with the introduction of skin-applied GLP-1 therapy. These innovative devices offer a likely simpler alternative to shots for individuals managing diabetes mellitus type 2 . They deliver a GLP-1 agonist directly through the epidermis, circumventing the